Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 37
1.
Br J Nutr ; 123(10): 1117-1126, 2020 05 28.
Article En | MEDLINE | ID: mdl-32077406

The study of polyphenols' effects on health has been gaining attention lately. In addition to reacting with important enzymes, altering the cell metabolism, these substances can present either positive or negative metabolic alterations depending on their consumption levels. Naringenin, a citrus flavonoid, already presents diverse metabolic effects. The objective of this work was to evaluate the effect of maternal naringenin supplementation during pregnancy on the tricarboxylic acid cycle activity in offspring's cerebellum. Adult female Wistar rats were divided into two groups: (1) vehicle (1 ml/kg by oral administration (p.o.)) or (2) naringenin (50 mg/kg p.o.). The offspring were euthanised at 7th day of life, and the cerebellum was dissected to analyse citrate synthase, isocitrate dehydrogenase (IDH), α-ketoglutarate dehydrogenase (α-KGDH) and malate dehydrogenase (MDH) activities. Molecular docking used SwissDock web server and FORECASTER Suite, and the proposed binding pose image was created on UCSF Chimera. Data were analysed by Student's t test. Naringenin supplementation during pregnancy significantly inhibited IDH, α-KGDH and MDH activities in offspring's cerebellum. A similar reduction was observed in vitro, using purified α-KGDH and MDH, subjected to pre-incubation with naringenin. Docking simulations demonstrated that naringenin possibly interacts with dehydrogenases in the substrate and cofactor binding sites, inhibiting their function. Naringenin administration during pregnancy may affect cerebellar development and must be evaluated with caution by pregnant women and their physicians.


Cerebellum/enzymology , Citric Acid Cycle/drug effects , Dietary Supplements , Flavanones/administration & dosage , Maternal Nutritional Physiological Phenomena , Animals , Citrate (si)-Synthase/drug effects , Female , Isocitrate Dehydrogenase/drug effects , Ketoglutarate Dehydrogenase Complex/drug effects , Malate Dehydrogenase/drug effects , Molecular Docking Simulation , Pregnancy , Rats , Rats, Wistar
2.
Stroke ; 49(5): 1223-1231, 2018 05.
Article En | MEDLINE | ID: mdl-29643256

BACKGROUND AND PURPOSE: Ischemic brain injury is characterized by 2 temporally distinct but interrelated phases: ischemia (primary energy failure) and reperfusion (secondary energy failure). Loss of cerebral blood flow leads to decreased oxygen levels and energy crisis in the ischemic area, initiating a sequence of pathophysiological events that after reoxygenation lead to ischemia/reperfusion (I/R) brain damage. Mitochondrial impairment and oxidative stress are known to be early events in I/R injury. However, the biochemical mechanisms of mitochondria damage in I/R are not completely understood. METHODS: We used a mouse model of transient focal cerebral ischemia to investigate acute I/R-induced changes of mitochondrial function, focusing on mechanisms of primary and secondary energy failure. RESULTS: Ischemia induced a reversible loss of flavin mononucleotide from mitochondrial complex I leading to a transient decrease in its enzymatic activity, which is rapidly reversed on reoxygenation. Reestablishing blood flow led to a reversible oxidative modification of mitochondrial complex I thiol residues and inhibition of the enzyme. Administration of glutathione-ethyl ester at the onset of reperfusion prevented the decline of complex I activity and was associated with smaller infarct size and improved neurological outcome, suggesting that decreased oxidation of complex I thiols during I/R-induced oxidative stress may contribute to the neuroprotective effect of glutathione ester. CONCLUSIONS: Our results unveil a key role of mitochondrial complex I in the development of I/R brain injury and provide the mechanistic basis for the well-established mitochondrial dysfunction caused by I/R. Targeting the functional integrity of complex I in the early phase of reperfusion may provide a novel therapeutic strategy to prevent tissue injury after stroke.


Brain/metabolism , Electron Transport Complex I/metabolism , Flavin Mononucleotide/metabolism , Glutathione/metabolism , Infarction, Middle Cerebral Artery/metabolism , Mitochondria/metabolism , Reperfusion Injury/metabolism , Animals , Brain/drug effects , Brain Ischemia/metabolism , Cerebrovascular Circulation , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Disease Models, Animal , Electron Transport Complex I/drug effects , Energy Metabolism , Glutathione/analogs & derivatives , Glutathione/pharmacology , Male , Mice , Mitochondria/drug effects , Oxidative Stress/drug effects , Random Allocation , Sulfhydryl Compounds/metabolism
3.
Future Microbiol ; 12: 867-879, 2017 08.
Article En | MEDLINE | ID: mdl-28686056

AIM: We investigated a proteome profile, protein-protein interaction and morphological changes of Mycobacterium tuberculosis after different times of eupomatenoid-5 (EUP-5) induction to evaluate the cellular response to the drug-induced damages. METHODS: The bacillus was induced to sub-minimal inhibitory concentration of EUP-5 at 12 h, 24 h and 48 h. The proteins were separated by 2D gel electrophoresis, identified by LC/MS-MS. Scanning electron microscopy and Search Tool for the Retrieval of Interacting Genes/Proteins analyses were performed. RESULTS: EUP-5 impacts mainly in M. tuberculosis proteins of intermediary metabolism and interactome suggests a multisite disturbance that contributes to bacilli death. Scanning electron microscopy revealed the loss of bacillary form. CONCLUSION: Some of the differentially expressed proteins have the potential to be drug targets such as citrate synthase (Rv0896), phosphoglycerate kinase (Rv1437), ketol-acid reductoisomerase (Rv3001c) and ATP synthase alpha chain (Rv1308).


Benzofurans/pharmacology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/metabolism , Phenols/pharmacology , Proteomics , Bacterial Proteins/drug effects , Bacterial Proteins/metabolism , Benzofurans/chemistry , Citrate (si)-Synthase/drug effects , Electrophoresis, Gel, Two-Dimensional , Genes, Bacterial/drug effects , Humans , Ketol-Acid Reductoisomerase/drug effects , Microbial Sensitivity Tests , Microscopy, Electron, Scanning , Mycobacterium tuberculosis/cytology , Mycobacterium tuberculosis/enzymology , Phenols/chemistry , Phosphoglycerate Kinase/drug effects , Protein Interaction Domains and Motifs , Proteome/analysis , Tandem Mass Spectrometry , Time Factors , Tuberculosis/drug therapy , Tuberculosis/microbiology
4.
Appl Microbiol Biotechnol ; 101(17): 6705-6712, 2017 Sep.
Article En | MEDLINE | ID: mdl-28755262

The effects of fungal elicitor on the physicochemical and microbial responses of Streptomyces natalensis HW-2 were investigated. The results showed that the elicitor could decrease dry cell weight (DCW) by 17.7% and increase the utilization of glucose, while the curve of pH was not obviously altered. The elicitor enhanced the yield of natamycin from 1.33 to 2.49 g/L. The morphology of the colony and the mycelium treated with elicitor showed significant differences from that of control. The level of intracellular reactive oxygen species (ROS) increased to 333.8 ng/L, which was a twofold increase comparing with the control. The concentration of Ca2+ reached 421.1 nmol/L, which increased by 32.8% after the addition of the elicitor. The activities of pyruvic carboxylase and phosphoenol pyruvate carboxylase were enhanced by 27.8 and 11.9%, respectively, while citrate synthase activity decreased by 23.1% in comparison with the control.


Fungal Proteins/pharmacology , Natamycin/biosynthesis , Streptomyces/drug effects , Streptomyces/metabolism , Calcium/analysis , Citrate (si)-Synthase/analysis , Citrate (si)-Synthase/drug effects , Culture Media/chemistry , Culture Media/pharmacology , Glucose/metabolism , Hydrogen-Ion Concentration , Microbiological Techniques , Pyruvate Carboxylase/analysis , Pyruvate Carboxylase/drug effects , Reactive Oxygen Species/metabolism
5.
Am J Physiol Heart Circ Physiol ; 312(1): H128-H140, 2017 Jan 01.
Article En | MEDLINE | ID: mdl-27836895

Duchenne Muscular Dystrophy (DMD) is associated with progressive cardiac pathology; however, the SIRT1/PGC1-α activator quercetin may cardioprotect dystrophic hearts. We tested the extent to which long-term 0.2% dietary quercetin enrichment attenuates dystrophic cardiopathology in Mdx/Utrn+/- mice. At 2 mo, Mdx/Utrn+/- mice were fed quercetin-enriched (Mdx/Utrn+/--Q) or control diet (Mdx/Utrn+/-) for 8 mo. Control C57BL/10 (C57) animals were fed a control diet for 10 mo. Cardiac function was quantified by MRI at 2 and 10 mo. Spontaneous physical activity was quantified during the last week of treatment. At 10 mo hearts were excised for histological and biochemical analysis. Quercetin feeding improved various physiological indexes of cardiac function in diseased animals. Mdx/Utrn+/--Q also engaged in more high-intensity physical activity than controls. Histological analyses of heart tissues revealed higher expression and colocalization of utrophin and α-sarcoglycan. Lower abundance of fibronectin, cardiac damage (Hematoxylin Eosin-Y), and MMP9 were observed in quercetin-fed vs. control Mdx/Utrn+/- mice. Quercetin evoked higher protein abundance of PGC-1α, cytochrome c, ETC complexes I-V, citrate synthase, SOD2, and GPX compared with control-fed Mdx/Utrn+/- Quercetin decreased abundance of inflammatory markers including NFκB, TGF-ß1, and F4/80 compared with Mdx/Utrn+/-; however, P-NFκB, P-IKBα, IKBα, CD64, and COX2 were similar between groups. Dietary quercetin enrichment improves cardiac function in aged Mdx/Utrn+/- mice and increases mitochondrial protein content and dystrophin glycoprotein complex formation. Histological analyses indicate a marked attenuation in pathological cardiac remodeling and indicate that long-term quercetin consumption benefits the dystrophic heart. NEW & NOTEWORTHY: The current investigation provides first-time evidence that quercetin provides physiological cardioprotection against dystrophic pathology and is associated with improved spontaneous physical activity. Secondary findings suggest that quercetin-dependent outcomes are in part due to PGC-1α pathway activation.


Antioxidants/pharmacology , Heart/drug effects , Muscular Dystrophy, Animal/physiopathology , Quercetin/pharmacology , Animals , Antigens, Differentiation/drug effects , Antigens, Differentiation/metabolism , Blotting, Western , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Cyclooxygenase 2/drug effects , Cyclooxygenase 2/metabolism , Cytochromes c/drug effects , Cytochromes c/metabolism , Disease Models, Animal , Electron Transport Chain Complex Proteins/drug effects , Electron Transport Chain Complex Proteins/metabolism , Fibronectins/metabolism , Food, Fortified , Heart/diagnostic imaging , Heart/physiopathology , Magnetic Resonance Imaging , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred mdx , Mitochondria, Muscle/drug effects , Mitochondria, Muscle/metabolism , Motor Activity , Muscular Dystrophy, Animal/metabolism , Muscular Dystrophy, Duchenne , Myocardium/metabolism , Myocardium/pathology , NF-KappaB Inhibitor alpha/drug effects , NF-KappaB Inhibitor alpha/metabolism , NF-kappa B/drug effects , NF-kappa B/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/drug effects , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism , Phosphorylation , Receptors, IgG/drug effects , Receptors, IgG/metabolism , Sarcoglycans/metabolism , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism , Transforming Growth Factor beta1/drug effects , Transforming Growth Factor beta1/metabolism , Utrophin/genetics , Utrophin/metabolism
6.
PLoS One ; 11(8): e0161413, 2016.
Article En | MEDLINE | ID: mdl-27537184

Methyltriphenylphosphonium (TPMP) salts have been widely used to measure the mitochondrial membrane potential and the triphenylphosphonium (TPP+) moiety has been attached to many bioactive compounds including antioxidants to target them into mitochondria thanks to their high affinity to accumulate in the mitochondrial matrix. The adverse effects of these compounds on cellular metabolism have been insufficiently studied and are still poorly understood. Micromolar concentrations of TPMP cause a progressive inhibition of cellular respiration in adherent cells without a marked effect on mitochondrial coupling. In permeabilized cells the inhibition was limited to NADH-linked respiration. We found a mixed inhibition of the Krebs cycle enzyme 2-oxoglutarate dehydrogenase complex (OGDHC) with an estimated IC50 3.93 [3.70-4.17] mM, which is pharmacologically plausible since it corresponds to micromolar extracellular concentrations. Increasing the lipophilic character of the used TPP+ compound further potentiates the inhibition of OGDHC activity. This effect of TPMP on the Krebs cycle ought to be taken into account when interpreting observations on cells and mitochondria in the presence of TPP+ derivatives. Compounds based on or similar to TPP+ derivatives may also be used to alter OGDHC activity for experimental or therapeutic purposes.


Citric Acid Cycle/drug effects , Ketoglutarate Dehydrogenase Complex/antagonists & inhibitors , Membrane Potential, Mitochondrial/drug effects , Onium Compounds/pharmacology , Trityl Compounds/pharmacology , Animals , Cell Line , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Glutamate Dehydrogenase/drug effects , Glutamate Dehydrogenase/metabolism , Isocitrate Dehydrogenase/drug effects , Isocitrate Dehydrogenase/metabolism , Ketoglutarate Dehydrogenase Complex/metabolism , Malate Dehydrogenase/drug effects , Malate Dehydrogenase/metabolism , Mitochondria, Muscle/drug effects , Mitochondria, Muscle/enzymology , Muscle, Skeletal/enzymology , Pyruvate Dehydrogenase Complex/drug effects , Pyruvate Dehydrogenase Complex/metabolism , Rats , Rats, Wistar
7.
Am J Physiol Endocrinol Metab ; 310(3): E213-24, 2016 Feb 01.
Article En | MEDLINE | ID: mdl-26646102

Decline in skeletal muscle mass and function starts during adulthood. Among the causes, modifications of the mitochondrial function could be of major importance. Polyunsaturated fatty (ω-3) acids have been shown to play a role in intracellular functions. We hypothesize that docosahexaenoic acid (DHA) supplementation could improve muscle mitochondrial function that could contribute to limit the early consequences of aging on adult muscle. Twelve-month-old male Wistar rats were fed a low-polyunsaturated fat diet and were given DHA (DHA group) or placebo (control group) for 9 wk. Rats from the DHA group showed a higher endurance capacity (+56%, P < 0.05) compared with control animals. Permeabilized myofibers from soleus muscle showed higher O2 consumptions (P < 0.05) in the DHA group compared with the control group, with glutamate-malate as substrates, both in basal conditions (i.e., state 2) and under maximal conditions (i.e., state 3, using ADP), along with a higher apparent Km for ADP (P < 0.05). Calcium retention capacity of isolated mitochondria was lower in DHA group compared with the control group (P < 0.05). Phospho-AMPK/AMPK ratio and PPARδ mRNA content were higher in the DHA group compared with the control group (P < 0.05). Results showed that DHA enhanced endurance capacity in adult animals, a beneficial effect potentially resulting from improvement in mitochondrial function, as suggested by our results on permeabilized fibers. DHA supplementation could be of potential interest for the muscle function in adults and for fighting the decline in exercise tolerance with age that could imply energy-sensing pathway, as suggested by changes in phospho-AMPK/AMPK ratio.


Cell Membrane/drug effects , Dietary Supplements , Docosahexaenoic Acids/pharmacology , Exercise Tolerance/drug effects , Mitochondria, Muscle/drug effects , Muscle, Skeletal/drug effects , Physical Endurance/drug effects , RNA, Messenger/drug effects , 3-Hydroxyacyl CoA Dehydrogenases/drug effects , 3-Hydroxyacyl CoA Dehydrogenases/metabolism , Animals , Blotting, Western , Calcium/metabolism , Calorimetry, Indirect , Cell Membrane/metabolism , Cholesterol/metabolism , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Electron Transport/drug effects , Hydrogen Peroxide/metabolism , Male , Mitochondria, Muscle/metabolism , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/metabolism , Muscle, Skeletal/metabolism , Oxygen Consumption/drug effects , Phospholipids/metabolism , Physical Conditioning, Animal , RNA, Messenger/metabolism , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Triglycerides/metabolism
9.
Neurosci Lett ; 487(3): 278-81, 2011 Jan 10.
Article En | MEDLINE | ID: mdl-20971158

A growing body of evidence has indicated that energy metabolism impairment may be involved in pathophysiology of some neuropsychiatric disorders. In this study, we evaluated the effect of acute and chronic administration of fluoxetine, olanzapine and the combination of fluoxetine/olanzapine on citrate synthase activity in brain of rats. For acute treatment, Wistar rats received one single injection of olanzapine (3 or 6mg/kg) and/or fluoxetine (12.5 or 25mg/kg). For chronic treatment, rats received daily injections of olanzapine (3 or 6mg/kg) and/or fluoxetine (12.5 or 25mg/kg) for 28 days. In the present study we observed that acute administration of olanzapine inhibited citrate synthase activity in cerebellum and prefrontal cortex. The acute administration of olanzapine increased citrate synthase activity in prefrontal cortex, hippocampus and striatum and fluoxetine increased citrate synthase activity in striatum. Olanzapine 3mg/kg and fluoxetine 12.5mg/kg in combination increased citrate synthase activity in prefrontal cortex, hippocampus and striatum. In the chronic treatment we did not observed any effect on citrate synthase activity. Our results showed that olanzapine and fluoxetine increased citrate synthase activity after acute, but not chronic treatment.


Benzodiazepines/pharmacology , Brain/drug effects , Citrate (si)-Synthase/drug effects , Fluoxetine/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacology , Animals , Brain/enzymology , Citrate (si)-Synthase/metabolism , Male , Olanzapine , Rats , Rats, Wistar
10.
Can J Anaesth ; 57(9): 836-42, 2010 Sep.
Article En | MEDLINE | ID: mdl-20645041

PURPOSE: Bupivacaine-induced myotoxicity is associated with mitochondrial bioenergetic alterations. The impact of the duration of bupivacaine treatment on mitochondrial energy production remains undetermined. Here, we assessed, in vivo, the alteration of mitochondrial metabolism following different durations of bupivacaine exposure (40, 56, or 112 hr) that correspond to 5, 7, or 14 repeated injections of 0.25% bupivacaine, respectively. METHODS: Rats were divided randomly into seven different groups: one control group (no catheter); three groups with normal saline injections (1 mL x kg(-1)) every eight hours via a femoral nerve catheter for 40, 56, and 112 hr, respectively; and three groups with 0.25% bupivacaine injections (1 mL x kg(-1)) every eight hours via a femoral nerve catheter for 40, 56, and 112 hr. Psoas and gracilis muscle samples located within the bupivacaine infusion-diffusion space were investigated. To estimate mitochondrial respiratory capacity, the protein content of the mitochondrial respiratory chain apparatus was evaluated by measuring citrate synthase activity. To measure mitochondrial respiratory function, adenosine diphosphate-stimulated oxygen consumption was measured by polarography in saponin-skinned muscle fibres using glutamate-malate or succinate as energy substrates. RESULTS: In psoas and gracilis muscles, saline solution had no effect on the two mitochondrial parameters. Bupivacaine induced a significant decrease in the citrate synthase activity in psoas (r(2) = 0.74; P < 0.001) and gracilis muscle (r(2) = 0.52; P < 0.001), and there was a significant decrease in the adenosine diphosphate-stimulated oxygen consumption using glutamate or succinate as substrates in both muscles (P < 0.001). CONCLUSIONS: The severity of bupivacaine-induced myotoxicity is closely linked to the duration of bupivacaine exposure in the muscle fibres located close to the catheter tip.


Anesthetics, Local/toxicity , Bupivacaine/toxicity , Energy Metabolism/drug effects , Mitochondria, Muscle/drug effects , Adenosine Diphosphate/administration & dosage , Anesthetics, Local/administration & dosage , Animals , Bupivacaine/administration & dosage , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Electron Transport/drug effects , Male , Mitochondria, Muscle/metabolism , Muscular Diseases/chemically induced , Muscular Diseases/physiopathology , Oxygen Consumption/drug effects , Polarography , Psoas Muscles/drug effects , Psoas Muscles/metabolism , Rats , Rats, Wistar , Time Factors
11.
Mol Cell Biochem ; 341(1-2): 245-9, 2010 Aug.
Article En | MEDLINE | ID: mdl-20372980

Bipolar disorder (BD) is a psychiatric disorder characterized by alternating episodes of mania and depression. The intracerebroventricular (i.c.v) administration of ouabain (a Na(+)/K(+)-ATPase inhibitor) in rats has been used as an animal model of mania, because present face, construct and predictive validities. Several studies strongly suggest that mitochondrial dysfunction play a central role in the pathophysiology of BD. Citrate synthase (CS) is an enzyme localized in the mitochondrial matrix and represents one of the most important steps of Krebs cycle. The aim of this study was to investigate CS activity in brain of rats after the administration of ouabain. Adult male Wistar rats received a single i.c.v. administration of ouabain (10(-2) and 10(-3) M) or vehicle (control group). Locomotor activity was measured using the open field task. CS activity was measured in the brain of rats immediately (1 h) and 7 days after ouabain administration. Our results showed that spontaneous locomotion was increased 1 h after ouabain administration, and that the hyperlocomotion persists 7 days after the administration. Moreover, CS activity was inhibited immediately after the administration of ouabain in the prefrontal cortex at the doses of 10(-3) and 10(-2) M. This inhibition remains by 7 days after the administration of ouabain. On the other hand, it was not observed any difference in CS activity in the hippocampus and striatum. Considering that inhibition of CS activity may reflect a mitochondrial dysfunction, it is tempting to speculate that the reduction of brain energy metabolism might be related to the pathophysiology of BD.


Bipolar Disorder/enzymology , Citrate (si)-Synthase/metabolism , Ouabain/pharmacology , Animals , Bipolar Disorder/chemically induced , Brain Chemistry/drug effects , Citrate (si)-Synthase/drug effects , Male , Motor Activity/drug effects , Ouabain/administration & dosage , Prefrontal Cortex/drug effects , Rats , Rats, Wistar
12.
Apoptosis ; 14(3): 276-86, 2009 Mar.
Article En | MEDLINE | ID: mdl-19165602

Cell death induced by oxidative insult targeted to mitochondrial interior of A431 cells was investigated. For stimulated production of ROS in the inner space of mitochondria, safranin-mediated photodynamic treatment (PDT) was employed. Another photosensitizer, mTHPC, which diffusely localizes to cellular membranes, was used for comparison. Cell response to the oxidative insult in mitochondrial interior was different from the response to the photodamage produced in cellular membranes. Autophagy and apoptotic features of cell death in response to mTHPC-PDT was observed in a wide range of PDT doses. Cell response to the oxidative stress in mitochondrial interior was dose-dependent. Damage up to CD50 did not reveal hallmarks of dead cells. At intermediate damage (CD50), cells manifested enhanced autophagy and reduced population of S-phase, but not apoptosis. Severe damage (beyond CD70) induced apoptosis following release of cytochrome c and caspase activation, in addition to autophagy and cell cycle arrest.


Apoptosis/physiology , Autophagy/physiology , Cell Cycle/physiology , Citrate (si)-Synthase/metabolism , Mitochondria/physiology , Photosensitizing Agents/pharmacology , Apoptosis/drug effects , Autophagy/drug effects , Caspase 3/metabolism , Cell Cycle/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/physiology , Citrate (si)-Synthase/drug effects , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Cytochromes c/metabolism , Humans , Indicators and Reagents/pharmacology , Mesoporphyrins/pharmacology , Mitochondria/drug effects , Phenazines/pharmacology , Photochemotherapy , Reactive Oxygen Species/metabolism
13.
J Inorg Biochem ; 102(8): 1631-7, 2008 Aug.
Article En | MEDLINE | ID: mdl-18482769

The primary Al-tolerance mechanism in plants involves exudation and/or accumulation of specific organic acid species, which form non-phytotoxic complexes with Al(3+) under physiological conditions. An evaluation was done of the role of organic acids in the tolerance mechanism of a cell suspension line of coffee Coffea arabica that exhibits Al-tolerance (LAMt) but for which the metabolic tolerance mechanism remains unknown. Significant differences existed in malate dehydrogenase and citrate synthase activities (key enzymes in organic acids metabolism) between protein extracts (day 7 of culture cycle) of the L2 (Al-sensitive) and LAMt (Al-tolerant) cells when cell suspensions were treated with 100 microM AlCl(3). HPLC analysis showed that the suspension cells of both lines exudate malate when incubated in a minimal solution but that exudation was not enhanced by treatment with AlCl(3) (100 microM). This is the first study demonstrating that plant Al-tolerance may be associated with down-regulation of malate dehydrogenase and citrate synthase activities.


Aluminum/pharmacology , Carboxylic Acids/metabolism , Coffea/metabolism , Drug Tolerance , Citrate (si)-Synthase/drug effects , Coffea/cytology , Coffea/drug effects , Coffea/enzymology , Down-Regulation/drug effects , Malate Dehydrogenase/drug effects , Malates
14.
Eur J Pharmacol ; 579(1-3): 318-25, 2008 Jan 28.
Article En | MEDLINE | ID: mdl-18054909

Studies on conjugated linoleic acid ingestion and its effect on cardiac tissue are necessary for the safe utilization of this compound as supplement for weight loss. Male Wistar 24-rats were divided into four groups (n=6):(C)given standard chow, water and 0.5 ml saline, twice a week by gavage; (C-CLA)receiving standard chow, water and 0.5 ml of conjugated linoleic acid, twice a week, by gavage; (S)given standard chow, saline by gavage, and 30% sucrose in its drinking water; (S-CLA)receiving standard chow, 30% sucrose in its drinking water and conjugated linoleic acid. After 42 days of treatment S rats had obesity with increased abdominal-circumference, dyslipidemia, oxidative stress and myocardial lower citrate synthase(CS) and higher lactate dehydrogenase(LDH) activities than C. Conjugated linoleic acid had no effects on morphometric parameters in C-CLA, as compared to C, but normalized morphometric parameters comparing S-CLA with S. There was a negative correlation between abdominal adiposity and resting metabolic rate. Conjugated linoleic acid effect, enhancing fasting-VO(2)/surface area, postprandial-carbohydrate oxidation and serum lipid hydroperoxide resembled to that of the S group. Conjugated linoleic acid induced cardiac oxidative stress in both fed conditions, and triacylglycerol accumulation in S-CLA rats. Conjugated linoleic acid depressed myocardial LDH comparing C-CLA with C, and beta-hydroxyacyl-coenzyme-A dehydrogenase/CS ratio, comparing S-CLA with S. In conclusion, dietary conjugated linoleic acid supplementation for weight loss can have long-term effects on cardiac health. Conjugated linoleic acid, isomers c9, t11 and t10, c12c9,t11" and "t10,c12" were changed to "c9, t11" and "t10, c12", respectively. Please check if appropriate.--> presented undesirable pro-oxidant effect and induced metabolic changes in cardiac tissue. Nevertheless, despite its effect on abdominal adiposity in sucrose-rich diet condition, conjugated linoleic acid may be disadvantageous because it can lead to oxidative stress and dyslipidemic profile.


Dietary Sucrose , Energy Metabolism/drug effects , Linoleic Acid/adverse effects , Oxidative Stress/drug effects , 3-Hydroxyacyl CoA Dehydrogenases/drug effects , 3-Hydroxyacyl CoA Dehydrogenases/metabolism , Abdominal Fat/drug effects , Animals , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Dyslipidemias/etiology , Isomerism , L-Lactate Dehydrogenase/drug effects , L-Lactate Dehydrogenase/metabolism , Linoleic Acid/pharmacology , Male , Obesity/drug therapy , Obesity/etiology , Oxidants/adverse effects , Oxidants/pharmacology , Rats , Rats, Wistar
15.
Neurochem Int ; 47(6): 385-93, 2005 Nov.
Article En | MEDLINE | ID: mdl-16095758

Li+ effects on glucose metabolism and on the competitive metabolism of glucose and lactate were investigated in the human neuroblastoma SH-SY5Y cell line using 13C NMR spectroscopy. The metabolic model proposed for glucose and lactate metabolism in these cells, based on tcaCALC best fitting solutions, for both control and Li+ conditions, was consistent with: (i) a single pyruvate pool; (ii) anaplerotic flux from endogenous unlabelled substrates; (iii) no cycling between pyruvate and oxaloacetate. Li+ was shown to induce a 38 and 53% decrease, for 1 and 15 mM Li+, respectively, in the rate of glucose conversion into pyruvate, when [U-13C]glucose was present, while no effects on lactate production were observed. Pyruvate oxidation by the tricarboxylic acid cycle and citrate synthase flux were shown to be significantly reduced by 64 and 84% in the presence of 1 and 15 mM Li+, respectively, suggesting a direct inhibitory effect of Li+ on tricarboxylic acid cycle flux. This work also showed that when both glucose and lactate are present as energetic substrates, SH-SY5Y cells preferentially consumed exogenous lactate over glucose, as 62% of the acetyl-CoA was derived from [3-13C]lactate while only 26% was derived from [U-13C]glucose. Li+ did not significantly affect the relative utilisation of these two substrates by the cells or the residual contribution of unlabelled endogenous sources for the acetyl-CoA pool.


Brain Chemistry/drug effects , Citric Acid Cycle/drug effects , Energy Metabolism/drug effects , Lithium/pharmacology , Neuroblastoma/metabolism , Acetyl Coenzyme A/biosynthesis , Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Bipolar Disorder/metabolism , Bipolar Disorder/physiopathology , Brain/drug effects , Brain/metabolism , Brain Chemistry/physiology , Carbon Isotopes , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/physiology , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Citric Acid Cycle/physiology , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Down-Regulation/physiology , Energy Metabolism/physiology , Feedback, Physiological/drug effects , Feedback, Physiological/physiology , Glucose/metabolism , Humans , Lactic Acid/metabolism , Magnetic Resonance Spectroscopy , Neurons/drug effects , Neurons/metabolism , Pyruvic Acid/metabolism
16.
Mol Cells ; 19(3): 328-33, 2005 Jun 30.
Article En | MEDLINE | ID: mdl-15995348

Small heat shock proteins (sHSPs) are widely distributed, and their function and diversity of structure have been much studied in the field of molecular chaperones. In plants, which frequently have to cope with hostile environments, sHSPs are much more abundant and diverse than in other forms of life. In response to high temperature stress, sHSPs of more than twenty kinds can make up more than 1% of soluble plant proteins. We isolated a genomic clone, NtHSP18.3, from Nicotiana tabacum that encodes the complete open reading frame of a cytosolic class I small heat shock protein. To investigate the function of NtHSP18.3 in vitro, it was overproduced in Escherichia coli and purified. The purified NtHSP18.3 had typical molecular chaperone activity as it protected citrate synthase and luciferase from high temperature-induced aggregation. When E. coli celluar proteins were incubated with NtHSP18.3, a large proportion of the proteins remained soluble at temperatures as high as 70 degrees . Native gel analysis suggested that NtHSP18.3 is a dodecameric oligomer as the form present and showing molecular chaperone activity at the condition tested. Binding of bis-ANS to the oligomers of NtHSP18.3 indicated that exposure of their hydrophobic surfaces increased as the temperature was raised. Taken together, our data suggested that NtHSP18.3 is a molecular chaperone that functions as a dodecameric complex and possibly in a temperature-induced manner.


Heat-Shock Proteins/physiology , Nicotiana/chemistry , Anilino Naphthalenesulfonates/metabolism , Citrate (si)-Synthase/drug effects , Cloning, Molecular , Cytosol/chemistry , Escherichia coli/metabolism , Escherichia coli Proteins/drug effects , Heat-Shock Proteins/isolation & purification , Hot Temperature , Luciferases/drug effects , Molecular Chaperones/physiology , Protein Denaturation/drug effects , Nicotiana/genetics
17.
Clin Pharmacol Ther ; 78(1): 60-8, 2005 Jul.
Article En | MEDLINE | ID: mdl-16003294

BACKGROUND: Myopathy, probably caused by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibition in skeletal muscle, rarely occurs in patients taking statins. This study was designed to assess the effect of high-dose statin treatment on cholesterol and ubiquinone metabolism and mitochondrial function in human skeletal muscle. METHODS: Forty-eight patients with hypercholesterolemia (33 men and 15 women) were randomly assigned to receive 80 mg/d of simvastatin (n = 16), 40 mg/d of atorvastatin (n = 16), or placebo (n = 16) for 8 weeks. Plasma samples and muscle biopsy specimens were obtained at baseline and at the end of the follow-up. RESULTS: The ratio of plasma lathosterol to cholesterol, a marker of endogenous cholesterol synthesis, decreased significantly by 66% in both statin groups. Muscle campesterol concentrations increased from 21.1 +/- 7.1 nmol/g to 41.2 +/- 27.0 nmol/g in the simvastatin group and from 22.6 +/- 8.6 nmol/g to 40.0 +/- 18.7 nmol/g in the atorvastatin group (P = .005, repeated-measurements ANOVA). The muscle ubiquinone concentration was reduced significantly from 39.7 +/- 13.6 nmol/g to 26.4 +/- 7.9 nmol/g (P = .031, repeated-measurements ANOVA) in the simvastatin group, but no reduction was observed in the atorvastatin or placebo group. Respiratory chain enzyme activities were assessed in 6 patients taking simvastatin with markedly reduced muscle ubiquinone and in matched subjects selected from the atorvastatin (n = 6) and placebo (n = 6) groups. Respiratory chain enzyme and citrate synthase activities were reduced in the patients taking simvastatin. CONCLUSIONS: High-dose statin treatment leads to changes in the skeletal muscle sterol metabolism. Furthermore, aggressive statin treatment may affect mitochondrial volume.


Cholesterol/analogs & derivatives , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Muscles/drug effects , Muscles/metabolism , Adult , Age Factors , Aged , Atorvastatin , Biopsy , Cholesterol/biosynthesis , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, HDL/drug effects , Cholesterol, LDL/blood , Cholesterol, LDL/drug effects , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Dose-Response Relationship, Drug , Double-Blind Method , Electron Transport/drug effects , Female , Heptanoic Acids/blood , Heptanoic Acids/pharmacology , Heptanoic Acids/therapeutic use , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hypercholesterolemia/drug therapy , Male , Middle Aged , Muscles/pathology , Patient Selection , Phytosterols/biosynthesis , Phytosterols/blood , Pyrroles/blood , Pyrroles/pharmacology , Pyrroles/therapeutic use , Sex Factors , Simvastatin/blood , Simvastatin/pharmacology , Simvastatin/therapeutic use , Sitosterols/blood , Succinate Cytochrome c Oxidoreductase/drug effects , Succinate Cytochrome c Oxidoreductase/metabolism , Time Factors , Ubiquinone/blood , Ubiquinone/chemistry
18.
J Cell Physiol ; 203(3): 589-98, 2005 Jun.
Article En | MEDLINE | ID: mdl-15605382

Thyroid hormone (TH) is an important regulator of mitochondrial content and activity. As mitochondrial content and properties differ depending on muscle-type, we compared mitochondrial regulation and biogenesis by T3 in slow-twitch oxidative (soleus) and fast-twitch mixed muscle (plantaris). Male Wistar rats were treated for 21 to 27 days with T3 (200 microg/kg/day). Oxidative capacity, regulation of mitochondrial respiration by substrates and phosphate acceptors, and transcription factors were studied. In soleus, T3 treatment increased maximal oxygen consumption (Vmax) and the activities of citrate synthase (CS) and cytochrome oxidase (COX) by 100%, 45%, and 71%, respectively (P < 0.001), whereas in plantaris only Vmax increased, by 39% (P < 0.01). ADP-independent respiration rate was increased in soleus muscle by 216% suggesting mitochondrial uncoupling. Mitochondrial substrate utilization in soleus was also influenced by T3, as were mitochondrial enzymes. Lactate dehydrogenase (LDH) activity was elevated in soleus and plantaris by 63% and 11%, respectively (P < 0.01), and soleus creatine kinase was increased by 48% (P < 0.001). T3 increased the mRNA content of the transcriptional co-activator of mitochondrial genes, PGC-1alpha, and the I and IV COX subunits in soleus. The muscle specific response to thyroid hormones could be explained by a lower content of TH receptors in plantaris than soleus. Moreover, TRalpha mRNA level decreased further after T3 treatment. These results demonstrate that TH has a major effect on mitochondrial content, regulation and coupling in slow oxidative muscle, but to a lesser extent in fast muscle, due to the high expression of TH receptors and PGC-1alpha transcription factor.


Energy Metabolism/drug effects , Energy Metabolism/physiology , Muscle Fibers, Fast-Twitch/metabolism , Muscle Fibers, Slow-Twitch/metabolism , Muscle, Skeletal/metabolism , Thyroid Hormones/pharmacology , Adenosine Diphosphate/metabolism , Animals , Cell Respiration/drug effects , Cell Respiration/physiology , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Electron Transport Complex IV/drug effects , Electron Transport Complex IV/metabolism , L-Lactate Dehydrogenase/drug effects , L-Lactate Dehydrogenase/metabolism , Male , Mitochondria/drug effects , Mitochondria/metabolism , Muscle Fibers, Fast-Twitch/drug effects , Muscle Fibers, Slow-Twitch/drug effects , Muscle, Skeletal/drug effects , Organ Culture Techniques , Oxidative Phosphorylation/drug effects , Oxygen Consumption/drug effects , Oxygen Consumption/physiology , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , RNA, Messenger/drug effects , RNA, Messenger/metabolism , RNA-Binding Proteins/genetics , Rats , Rats, Wistar , Thyroid Hormone Receptors alpha/genetics , Transcription Factors/genetics , Triiodothyronine/pharmacology , Up-Regulation/drug effects , Up-Regulation/physiology
19.
J Am Coll Cardiol ; 44(6): 1320-7, 2004 Sep 15.
Article En | MEDLINE | ID: mdl-15364339

OBJECTIVES: We sought to determine if physical inactivity affects endothelial function in young healthy individuals. BACKGROUND: Recent studies have linked exercise training to increased bioavailability of vascular nitric oxide (NO) and to improved endothelial function in patients with cardiovascular disorders. The effects of physical inactivity on normal vascular endothelial function are not known. METHODS: Healthy young male C57Bl/6 mice living in groups of five in large cages, where they were running, climbing, and fighting during their active cycle, were randomly assigned to stay there or to live alone in small cages where they were predominantly resting. After five and nine weeks citrate synthase activity (a measure of mitochondrial respiratory chain activity), heart weight/body weight ratio, vascular reactivity, and protein expression of endothelial nitric oxide synthase (eNOS) were assessed. RESULTS: Singularized mice showed a reduction of citrate synthase activity (p < 0.05), of endothelium-dependent vasorelaxation (to 65 +/- 5% of control levels; p < 0.001), and of eNOS protein expression (to 53 +/- 8% of control levels; p < 0.01). In striking contrast, vascular responses to potassium chloride, phenylephrine, and the NO-donor racemic S-nitroso-N-acetylpenicillamine were unchanged. The alterations of vascular eNOS-activity were completely reversible when singularized mice underwent exercise. In mice living in groups, exercise showed only a small effect on aortic eNOS expression. CONCLUSIONS: In young healthy individuals physical inactivity induces endothelial dysfunction, which is completely reversible by a short period of moderate exercise training. We suggest that physical inactivity, the so-called sedentary lifestyle, increases cardiovascular risk in young healthy individuals by inducing endothelial dysfunction.


Endothelium, Vascular/physiopathology , Motor Activity/physiology , Acetylcholine/administration & dosage , Animals , Aorta/enzymology , Aorta/physiopathology , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Endothelium, Vascular/enzymology , Heart Ventricles/enzymology , Heart Ventricles/physiopathology , Life Style , Male , Mice , Mice, Inbred C57BL , Models, Cardiovascular , Muscle, Smooth, Vascular/enzymology , Muscle, Smooth, Vascular/physiopathology , Myocardial Contraction/drug effects , Myocardial Contraction/physiology , Myocardium/enzymology , Myocardium/pathology , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase/drug effects , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III , Vasodilation/drug effects , Vasodilation/physiology , Vasodilator Agents/administration & dosage
20.
Muscle Nerve ; 28(3): 324-9, 2003 Sep.
Article En | MEDLINE | ID: mdl-12929192

Previous studies suggested that administration of cyclosporin A (CsA), an immunosuppressive agent, contributes to the increased fatigability of heart transplant recipients. The aim of this study was to investigate whether CsA itself, without vehicle, affects the function of mitochondria maintained in situ, in rats treated with CsA (25mg/kg/day) dissolved in ethanol and olive oil. Treatment with CsA induced a 16% decrease in slow myosin heavy chain (MHC) associated with a 225% increase in fast MHCIIa. The proportion of fibers expressing type IIa MHC increased as a result of CsA treatment. Soleus from the CsA-treated animals showed an increase in both basal (+85%) and maximal (+37%) mitochondrial respiration (P < 0.001), consistent with a 24% increase in citrate synthase activity, whereas the apparent Km for adenosine diphosphate was unchanged. By itself, CsA has no deleterious effects on muscle oxidative capacity but induces alterations in energy metabolism in accordance with the increased proportion of fast-twitch oxidative fibers.


Cyclosporine/adverse effects , Heart Transplantation/adverse effects , Immunosuppressive Agents/adverse effects , Muscle Fatigue/drug effects , Muscle, Skeletal/drug effects , Animals , Citrate (si)-Synthase/drug effects , Citrate (si)-Synthase/metabolism , Immunohistochemistry , Male , Mitochondria/drug effects , Mitochondria/metabolism , Muscle Fatigue/physiology , Muscle Fibers, Fast-Twitch/cytology , Muscle Fibers, Fast-Twitch/drug effects , Muscle Fibers, Fast-Twitch/metabolism , Muscle, Skeletal/cytology , Muscle, Skeletal/metabolism , Myosin Type II/drug effects , Myosin Type II/metabolism , Oxidative Phosphorylation/drug effects , Rats , Rats, Wistar , Up-Regulation/drug effects , Up-Regulation/physiology
...